You have no items in your shopping cart.
Anti-Spike RBD Reference Antibody (Cilgavimab)
Description
Images & Validation
−| Tested Applications | ELISA, FC |
|---|---|
| Reactivity | Virus |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Source/Expression System | CHO Cell |
| Molecular Weight | 148.82 |
| Endotoxin | < 0.001EU/μg,determined by LAL method. |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
|---|---|
| Form/Appearance | Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column. |
| Concentration | 1mg/ml |
| Disclaimer | For research use only |

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

The purity of Anti-Spike RBD Reference Antibody (Cilgavimab) is more than 99.35%, determined by SEC-HPLC.

Immobilized 2019nCoV RBD His at 2 µg/mL can bind Anti-Spike RBD Reference Antibody (Cilgavimab), EC50=0.01122 µg/mL.

Anti-Spike RBD Reference Antibody (Cilgavimab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%
Documents Download
Request a Document
Protocol Information
Anti-Spike RBD Reference Antibody (Cilgavimab) (orb1818481)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review